Jefferies initiates coverage on AVEO Pharmaceuticals (NASDAQ: AVEO) with a Buy rating and $30 price target.

The firm cited ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE